Wednesday, September 23, 2026

TagsModeratetoSevere

Tag: ModeratetoSevere

Healthcare

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

BFN's Desk - March 30, 2026 0

Automobile

Adiso Therapeutics Announces Positive Topline Data from Phase 1b Study of ADS051 for the Treatment of Moderate-to-Severe Ulcerative Colitis

BFN's Desk - October 23, 2023 0

Most Read

House of McDowell’s Soda Reimagines Yaari with ‘Yaari Ki Nayi Vibe’

September 20, 2026

Black Dog Scotch Whisky In New Packaging

September 11, 2026

Madhya Pradesh Unveils Roadmap to Cut Major Non-CO₂ Pollutants

September 8, 2026

Sanchi Gets a New Identity in Indore, Reinforcing Its 45-Year Legacy of Trust

August 26, 2026